Active	Status	Sponsor type	Region	Phase	Filter
3 Active 9 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Anjeso (meloxicam IV) / Baudax Bio
NCT05315479: Safety and Pharmacokinetics of N1539 in Children 2 to <17 Years of Age Following Surgery	Terminated	4	19	US	N1539, Meloxicam IV	Baudax Bio	Post Operative Pain	07/22	07/22
NCT05291598: Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)	Completed	3	223	US	IV meloxicam, Ketorolac	University of Miami	Total Knee Replacement, Total Hip Replacement	05/23	05/23
NCT06379165: Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain	Completed	3	192	RoW	Meloxicam Nanocrystal Injection, Placebo	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.	Pain	07/23	07/23